Anova is a clinical research technology company focused on transforming how clinical trials are conducted by connecting sponsors, investigators, sites and patients through a unified digital platform. Founded in 2017 and headquartered in Illinois, the company operates globally with additional presence in the United Kingdom.

The company’s core offering is its proprietary AnovaOS™ platform, a SaaS-based system designed to integrate the global clinical research ecosystem. This platform enables real-time connectivity between sponsors, research sites and physicians, allowing for efficient study feasibility, activation and patient enrolment.

Anova’s model is centred on improving access to clinical trials and accelerating drug development timelines. By standardising workflows and automating key processes, the platform helps reduce development costs, improve data quality and enable faster delivery of new therapies to patients.

The platform aggregates a large global network, including tens of thousands of research sites, investigators and active studies, enabling physicians to match patients to suitable clinical trials or compassionate use programmes at the point of care.

Anova positions itself as a technology-enabled research organisation, combining elements of a CRO with digital infrastructure to facilitate collaboration, evidence generation and precision medicine-driven clinical development.

Key products and services

AnovaOS™ clinical research platform

• SaaS platform integrating sponsors, sites, investigators and patients
• Real-time access to global clinical trials and investigational products
• Workflow automation for feasibility, activation and enrolment

Patient matching and recruitment

• AI-enabled matching of patients to clinical trials
• Automated eligibility screening against study protocols
• Support for both clinical trials and compassionate use programmes

Clinical trial acceleration and management

• Rapid site activation (within days using standardised processes)
• Streamlined regulatory workflows and data capture
• Integrated monitoring and study management capabilities

Global research network

• Access to thousands of sponsors, studies and research sites
• Direct connectivity between physicians and trial sponsors
• Collaboration tools for investigators and study teams

Real-world data and evidence generation

• Patient registry studies and real-world data collection
• Data insights to improve trial design and outcomes
• Support for precision medicine and personalised treatment approaches

By combining a global clinical research network with a technology-driven platform, Anova is redefining how clinical trials are designed, executed and accessed. Its focus on automation, connectivity and patient-centric development positions the company as an emerging innovator at the intersection of CRO services and digital health infrastructure, enabling faster and more inclusive access to new therapies worldwide.